Dharam Kumbhani

Cardiologists and researchers Kim Eagle, Dharam Kumbhani, Payal Kohli, and Ajay Kirtane discuss late-breaking science from the American Heart Association Scientific Sessions 2023, covering topics such as blood pressure targets, transfusion strategies for anemic heart attack patients, complete revascularization, risk stratification, and an AI-based approach to assess fat attenuation as a risk marker in cardiology.

Guests Kim Eagle, Dharam Kumbhani, Payal Kohli, and Ajay Kirtane discuss late-breaking clinical trials from the American Heart Association Scientific Sessions. Topics include the safety and efficacy of a novel agent called Abecidimap, concerns about a new antibody mechanism for lenticoagulation, and the use of digital technology in gathering information about acrofibulation and reducing heart disease risk in HIV patients.

Cardiologists Dharam Kumbhani, Ki Park, and Ajay Kirtane discuss the results of the pooled analysis of the radiant trials, showing that renal denervation can significantly reduce blood pressure. They also explore the potential approval of renal denervation in the US and present a quality of life analysis of tricuspid transcatheter edge-to-edge repair.